The cost of diabetes-related preventable hospitalizations in the United States rose 1.6% annually between 2001 and 2014—mostly due to an increase in the number of people with diabetes as well as the rising cost of hospital stays.
“Our comprehensive state-specific estimates provide essential information needed by state policymakers to monitor the economic burden of the disease and to better plan and evaluate interventions for preventing type 2 diabetes and managing diabetes in their states,” researchers wrote.
If a fifth of the 30 million patients with type 2 diabetes used dietary changes to drop their HbA1c level by 1%, the health care system could save at least $10 billion annually and outcomes would improve measurably, according to a recent report.
A global epidemic of type 2 diabetes is fueling record demand for insulin but tens of millions will not get the injections they need, a new study concluded.
“Multidisciplinary collaborative care appeared to positively impact on the clinical, humanistic, and economic outcomes of patients with uncontrolled diabetes,” researchers concluded.